MobiHealth News May 14, 2024
Jessica Hagen

The Delaware-based company provides self-insured employers with data and strategies to reduce costs associated with prescription medications.

Truveris, a health technology company focused on decreasing prescription costs for employers and their members, announced it had secured $15 million in Series E investment.

Existing investors Canaan Partners and New Leaf Venture Partners led the round.

WHAT IT DOES

The company provides technology to help employers secure lower drug pricing plans. Its software also allows sponsors to garner data-driven insights to reduce prescription costs, improve pharmacy benefit manager-contract terms and increase medication access.

The funds will be used to support the company’s operational growth.

“There has never been more attention placed on PBM practices and the impact on pharmacy...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Employer, Investments, Pharma, Pharma / Biotech, Trends
The High Price of Treatment Resistant Depression for Employers
The Pandemic Proved That Remote Leadership Works
More than 65 Organizations Call on Workplaces to Provide Comprehensive Obesity Care Coverage
The state of AI: How organizations are rewiring to capture value
To reduce healthcare costs, address chronic conditions

Share This Article